在鼠标抑制器屏幕中发现了MITF调节的新机制
Hong Nhung Vu1, Matti Már Valdimarsson2, Sara Sigurbjörnsdóttir1
1Department of Biochemistry and Molecular Biology, BioMedical Center, Faculty of Medicine, University of Iceland, Sturlugata 8, 102, Reykjavík, Iceland.
EMBO reports
|August 21, 2024
概括
基因查发现了与微眼膜相关的转录因子 (MITF) 中的突变,该突变增强了核局部化和稳定性. 这一发现揭示了一种新的基因抑制机制,解释了突变如何导致正常的表型.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 细胞生物学 细胞生物学
背景情况:
- 微相关转录因子 (MITF) 对于黑色素细胞的发育至关重要,并充当瘤基因.
- 了解MITF调节是理解色素和黑色素瘤的关键.
- 基因选是识别新型监管机制的强大工具.
研究的目的:
- 为了确定Mitf相关的色素缺陷的遗传抑制剂.
- 阐明MITF调节背后的分子机制及其对表型的影响.
- 为了研究MITF突变,SUMOylation和酸化之间的相互作用.
主要方法:
- 在小鼠中进行遗传查,以确定Mitf色素表型的抑制剂.
- 影响 K316 SUMOylation 位点的内基因 Mitf 突变的表征.
- 生物化学和生物物理分析,包括smFRET,以研究蛋白质相互作用和局部化.
- 在MITF中分析与黑色素瘤相关的突变.
主要成果:
- 鉴定了一种内基因MITF突变,导致MITF在K316SUMOylation位点的截断,以及C端内在失调区域 (IDR) 的损失.
- 截断的MITF蛋白呈现出增加的核局部化和改变的稳定性,同时保留了DNA结合能力.
- 突变的MITF二次体可以稳定核中的野生类型和突变的MITF伙伴,确保核MITF供应.
- 在单体中观察到K316 SUMOylation和S409酸化位之间的相互作用,解释了表型效应.
- 与黑色素瘤相关的E318K突变影响K316SUMOylation,并与S409酸化相互作用.
结论:
- 在K316的SUMOylation和S409的酸化是通过构造变化影响核局部化和稳定的关键调节部位.
- 发现了一种新的基因抑制机制,涉及MITF截断和改变的蛋白质-蛋白质相互作用.
- 矛盾的是,有害突变可以通过补偿性调节机制导致正常的表型.
相关概念视频
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K


